The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, J. S.
Right arrow Articles by Claflin, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, J. S.
Right arrow Articles by Claflin, J. L.

The Journal of Immunology, Vol 146, Issue 10 3652-3655, Copyright © 1991 by American Association of Immunologists


ARTICLES

Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus

JS Weber, J Berry, T Manser and JL Claflin
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109-0620.

Somatic hypermutation is known to occur in the VJ kappa exon and its flanking sequences, yet little is known about the hypermutation mechanism or its exact target within the rearranged locus. Mutations may occur at the same frequency, spanning a region from the leader intron to 3' of J kappa 5, regardless of which J is chosen for VJ rearrangement. Another possibility is that mutations may be limited to the rearranged VJ kappa and its immediate flanking sequences. To distinguish between these possibilities, the JC introns of 21 alleles with V kappa rearranged to J kappa 1 were sequenced, and mutations were located. The frequency of mutations was determined for different sections of the intron and compared with the frequencies of mutations found in the JC intron of a set of VJ kappa 5 alleles. The results showed that mutations were concentrated in and around the rearranged VJ, regardless of whether J kappa 1 or J kappa 5 was used. These data imply that the hypermutational mechanism focuses on rearranged V genes.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. A. Inlay, H. H. Gao, V. H. Odegard, T. Lin, D. G. Schatz, and Y. Xu
Roles of the Ig {kappa} Light Chain Intronic and 3' Enhancers in Igk Somatic Hypermutation
J. Immunol., July 15, 2006; 177(2): 1146 - 1151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Oprea, L. G. Cowell, and T. B. Kepler
The Targeting of Somatic Hypermutation Closely Resembles That of Meiotic Mutation
J. Immunol., January 15, 2001; 166(2): 892 - 899.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. K.-K. Ching, P.-S. Li, W.-Y. Chan, C.-H. Ma, S. S.-T. Lee, P.-L. Lim, and Y.-L. Chui
Strand bias in Ig somatic hypermutation is determined by signal sequence within the variable region
Int. Immunol., September 1, 2000; 12(9): 1245 - 1253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. G. Cowell and T. B. Kepler
The Nucleotide-Replacement Spectrum Under Somatic Hypermutation Exhibits Microsequence Dependence That Is Strand-Symmetric and Distinct from That Under Germline Mutation
J. Immunol., February 15, 2000; 164(4): 1971 - 1976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Shapiro, K. Aviszus, D. Ikle, and L. J. Wysocki
Predicting Regional Mutability in Antibody V Genes Based Solely on Di- and Trinucleotide Sequence Composition
J. Immunol., July 1, 1999; 163(1): 259 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Kim, K. Kage, F. Matsuda, M.-P. Lefranc, and U. Storb
B Lymphocytes of Xeroderma Pigmentosum or Cockayne Syndrome Patients with Inherited Defects in Nucleotide Excision Repair Are Fully Capable of Somatic Hypermutation of Immunoglobulin Genes
J. Exp. Med., August 4, 1997; 186(3): 413 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Tumas-Brundage and T. Manser
The Transcriptional Promoter Regulates Hypermutation of the Antibody Heavy Chain Locus
J. Exp. Med., January 20, 1997; 185(2): 239 - 250.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Goyenechea and C. Milstein
Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation
PNAS, November 26, 1996; 93(24): 13979 - 13984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.